Adverum Biotech
5 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Org chart
Laurent Fischer
Collapse
Star Seyedkazemi
Chief Development Officer
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
John Rakow
General Counsel
Dena House
SVP, Human Resources, Organizational Development & Learning
Carla Fiankan
SVP, Regulatory Affairs
Heikki Jouttijärvi
SVP & Head, Technical Operations
Bill Tan
SVP & Head, Global Clinical Operations
Rabia Gurses Ozden
Chief Medical Officer
Adam Turpcu
Vice President, Clinical Development And Access Strategy
Joanna D.
Associate Director, Clinical Development
Senior Director, Global Commerical Strategy
Vacant position
